Chao‐Wei Hsu

2.1k citations
72 papers · 1.6k indexed · 1 hit paper · h-index 19
Topics
Hepatitis C virus research (53 papers)Hepatitis B Virus Studies (50 papers)Liver Disease Diagnosis and Treatment (41 papers)

In The Last Decade

Chao‐Wei Hsu

67 papers receiving 1.5k citations

Hit Papers

Telbivudine versus Lamivudine in Patients with Chronic He...20072026201320192007100200300400500

Peers

Chao‐Wei Hsu
Comparison fields: 5 of 77
  • Epidemiology 1.3k
  • Hepatology 1.3k
  • Infectious Diseases 139
  • Oncology 99
  • Surgery 80
Replace G. Bellati with:
G. Bellati Italy
Haruhiko Kobashi Japan
Yukio Gibo Japan
Speranţa Iacob Romania
Sheng‐Nan Lu Taiwan
Rodolphe Sobesky France
Alessia Ciancio Italy
Ziv Ben‐Ari Israel
Kuo‐Chin Chang Taiwan
Albert D. Min United States
Chao‐Wei Hsu relative to G. Bellati Italy G. Bellati's profile →
Citations per field
00.5×10×12.6×
G. Bellati · 1×
Citations per year

Countries citing papers authored by Chao‐Wei Hsu

Since Specialization
Citations

This map shows the geographic impact of Chao‐Wei Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao‐Wei Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao‐Wei Hsu more than expected).

Fields of papers citing papers by Chao‐Wei Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chao‐Wei Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao‐Wei Hsu. The network helps show where Chao‐Wei Hsu may publish in the future.

Co-authorship network of co-authors of Chao‐Wei Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Chao‐Wei Hsu. A scholar is included among the top collaborators of Chao‐Wei Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chao‐Wei Hsu. Chao‐Wei Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 2
4 2
5 6
6 1
7 1
8 23
9 16
10 17
11 3
12 2
13 12
14 9
15 19
16 37
17 43
18 28
19 9
20 8

About Chao‐Wei Hsu

Chao‐Wei Hsu is a scholar working on Hepatology, Epidemiology and Transplantation, having authored 72 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hepatitis C virus research (53 papers), Hepatitis B Virus Studies (50 papers) and Liver Disease Diagnosis and Treatment (41 papers). The work is most often cited by research in Hepatology (1.3k citations), Epidemiology (1.3k citations) and Infectious Diseases (139 citations). Chao‐Wei Hsu has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include Yun‐Fan Liaw, Chau‐Ting Yeh, Yi‐Cheng Chen, Rong‐Nan Chien, Edward Gane, Satawat Thongsawat, Yuming Wang, Ching‐Lung Lai, Ming‐Ling Chang and Stefan Zeuzem. Their work appears in journals such as New England Journal of Medicine, Gastroenterology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026